About

About Ardena Ardena is as a fully integrated Contract Development and Manufacturing Organization (CDMO), with a core focus on bringing molecules to the clinics. Our comprehensive suite of services caters to every stage of pharmaceutical development, ensuring a smooth progression from initial idea to clinical application. From small-molecule API projects, to drug product development, navigating phase-appropriate processes under cGMP conditions, and facilitating clinical packaging and logistics. Furthermore, as experts in nanomedicine development, we offer scalable formulation, process, and analytical development, alongside GMP manufacturing, ensuring our partners meet their clinical schedules effectively. Ardena is also recognized for its expertise in bioanalysis solutions that cater to diverse drug products and biomarkers, spanning small molecules to proteins, including antibodies, ADCs, oligonucleotides, and vaccines. As your trusted CDMO partner connect with our team at the California Pavilion and let us assist you on your journey towards clinical success. About Ardena Ardena is as a fully integrated Contract Development and Manufacturing Organization (CDMO), with a core focus on bringing molecules to the clinics. Our comprehensive suite of services caters to every stage of pharmaceutical development, ensuring a smooth progression from initial idea to clinical application. From small-molecule API projects, to drug product development, navigating phase-appropriate processes under cGMP conditions, and facilitating clinical packaging and logistics. Furthermore, as experts in nanomedicine development, we offer scalable formulation, process, and analytical development, alongside GMP manufacturing, ensuring our partners meet their clinical schedules effectively. Ardena is also recognized for its expertise in bioanalysis solutions that cater to diverse drug products and biomarkers, spanning small molecules to proteins, including antibodies, ADCs, oligonucleotides, and vaccines. As your trusted CDMO partner connect with our team at the California Pavilion and let us assist you on your journey towards clinical success. Ardena is a specialist CDMO and bioanalytical CRO advancing precision medicines and other complex therapies from early development through to commercial supply. The company supports biotech and pharmaceutical partners in translating challenging molecules into scalable, robust therapies. Its strength lies in combining complex drug product development and GMP manufacturing, bioanalytical services, and specialized expertise in nanomedicine and conjugates within one integrated framework. This approach reduces complexity, shortens timelines, and supports efficient progression across development stages. Ardena focuses on modalities that demand advanced formulation and analytical precision, including nanoparticles, conjugates, and other complex drug products. In nanomedicine, the company supports lipid-based, polymer-based, and metal-based systems, optimizing formulation, scalability, and manufacturability. Drug product capabilities span formulation development, process scale-up, and GMP manufacturing for clinical and commercial supply. Enabling technologies such as spray drying and hot melt extrusion address solubility, stability, and bioavailability challenges, alongside expertise in highly potent and complex dosage forms. Ardena also supports the development of conjugates, including antibody-drug conjugates (ADCs) and other novel conjugates (XDCs). These programs require tight integration of chemistry, formulation, and analytics, combined with containment and GMP expertise to ensure consistency from early development through to commercial manufacturing. Bioanalytical services are a central pillar, delivering pharmacokinetic, biomarker, and immunogenicity analysis to support clinical development and regulatory submissions. Ardena operates established bioanalytical laboratories in Europe and has expanded into the United States with a new lab in Somerset. Ardena’s international network spans Europe and the US, enabling regional flexibility and continuity from development to commercialization. The Somerset site plays a key role, offering GMP drug product manufacturing for clinical and commercial supply, alongside integrated bioanalytical capabilities. As an FDA-approved facility, it provides a strong foundation for programs targeting the US market, with clear advantages in supply chain efficiency and market access. What differentiates Ardena is the integration of its expertise. Multidisciplinary teams align development, manufacturing, and analysis from the outset, reducing rework and supporting consistent execution. Supporting capabilities in solid-state research and CMC development further strengthen programs and de-risk critical decisions. At this event, Ardena brings practical insight across the full development lifecycle, supporting focused discussions on how to advance complex therapies with speed, control, and confidence. Visit Ardena at booth 3253. Ardena enables progress where complexity defines the challenge.